Porphyria is a group of genetic disorders that result in built-up of chemicals called porphyrins in the body. Porphyrins are normally converted into heme, a constituent of hemoglobin with the help of ...

Variegate porphyria (VP) is an autosomal dominant condition that results from the deficiency of protoporphyrinogen oxidase (PPOX, EC 1.3). The build-up of porphyrin precursors delta-aminolevulinic ...

This page lists all known medications that could potentially lead to 'Variegate porphyria' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Acute hepatic porphyria (AHP) is one of a group of disorders that are triggered by a buildup of pigments called porphyrins in your liver and elsewhere. The disorder can cause nerve problems and other ...

Study results published in PLoS One strongly suggest machine learning can be an effective approach to identify patients who should receive a diagnostic biochemical test to screen for acute hepatic ...

Porphyria cutanea tarda (PCT) is the most common porphyria, a group of acquired or genetic disorders of heme biosynthesis with cutaneous and/or systemic manifestations. [1] Classic PCT presents with ...

Use of the RNA inhibitor givosiran was shown to reduce expression of delta-aminolevulinic acid synthase 1, in turn reducing the severity of acute attacks and chronic symptoms for patients with severe ...

"Porphyria Pipeline 2025"DelveInsight's, "Porphyria - Pipeline Insight, 2025,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Porphyria pipeline landscape. It ...

Dublin, Nov. 15, 2021 (GLOBE NEWSWIRE) -- The "Porphyria: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031" report has been added to ResearchAndMarkets.com's offering. This ...

If you’ve spent the last week binging “Queen Charlotte: A Bridgerton Story,” you’re likely well-versed in the complicated (and steamy!) love between Queen Charlotte and King George III. But this ...